| | CLIC3-high (n = 49) | CLIC3-low (n = 58) | p-value |
|---|
Gender |
Male | 32 | 41 | 0.5516 |
Female | 17 | 17 |
Age |
≥ 65 | 35 | 39 | 0.6399 |
< 65 | 14 | 19 |
pT |
T1a–T2 | 17 | 10 | 0.0381* |
T3–T4b | 32 | 48 |
pN |
N0 | 15 | 17 | 0.8835 |
N1–3 | 34 | 41 |
H |
H0 | 47 | 54 | 0.5234 |
H1 | 2 | 4 |
P |
P0 | 44 | 55 | 0.3241 |
P1 | 5 | 3 |
M |
M0 | 37 | 41 | 0.5754 |
M1 | 12 | 17 |
CY |
CY0 | 43 | 48 | 0.4676 |
CY1 | 6 | 10 |
pStage |
IA–IIB | 26 | 22 | 0.1165 |
IIIA–IV | 23 | 36 |
Histology |
pap/tub1/tub2 | 17 | 30 | 0.0913 |
por1/por2/sig/muc | 31 | 28 |
ly |
− | 8 | 7 | 0.5282 |
+ | 41 | 51 |
v |
− | 11 | 14 | 0.8369 |
+ | 38 | 44 |
- pT pathological tumor depth, T1a tumor invades lamina propria or muscularis mucosae, T1b tumor invades submucosa, T2 tumor invades muscularis propria, T3 tumor invades subserosa, T4a tumor perforates serosa, T4b tumor invades adjacent structures, pN pathological lymph node metastasis, N0 no regional lymph node metastasis, N1 metastasis in 1 to 2 regional lymph nodes, N2 metastasis in 3 to 6 regional lymph nodes, N3 metastasis in 7 or more regional lymph nodes, H liver metastasis; H0 no liver metastasis, H1 liver metastasis, P peritoneal dissemination, P0 no peritoneal dissemination, P1 peritoneal disseminationm, M distant metastasis, M0 no distant metastasis, M1 distant metastasis, CY peritoneal lavage cytology, CY0 no peritoneal lavage cytology, CY1 peritoneal lavage cytology, pStage pathological stage (TNM stage), StageIA T1N0M0, StageIB T1N1M0 or T2N0M0, StageIIA T1N2M0 or T2N1M0 or T3N0M0, StageIIB T1N3aM0 or T2N2M0 or T3N1M0 or T4aN0M0, StageIIIA T2N3aM0 or T3N2M0 or T4aN1M0 or T4aN2M0 or T4bN0M0, StageIIIB T1N3bM0 or T2N3bM0 or T3N3aM0 or T4aN3aM0 or T4bN1M0 or T4bN2M0, StageIIIC T3N3bM0 or T4aN3bM0 or T4bN3aM0 or T4bN3bM0, StageIV anyTanyNM1. Histology, pap papillary adenocarcinoma, tub1 well differentiated tubular adenocarcinoma, tub2 moderately differentiated tubular adenocarcinoma, por1 solid type poorly differentiated adenocarcinoma, por2 non-solid type poorly differentiated adenocarcinoma, sig signet-ring cell carcinoma, muc mucinous adenocarcinoma, ly lymphatic invasion, ly (−) no lymphatic invasion, ly ( +) lymphatic invasion, v venous invasion, v (−) no venous invasion, v ( +) venous invasion
